By Caoimhe Toman
Date: Friday 21 Dec 2018
LONDON (ShareCast) - (Sharecast News) - Dechra Pharmaceuticals: Numis upgrades to add with a target price of 2,525p.
Headlam Group: Peel Hunt downgrades to hold with a target price of 460p.
Bakkavor Group: Peel Hunt reiterates buy with a target price of 200p.
Quixant: Peel Hunt reiterates buy with a target price of 500p.
GAN: Liberum reiterates buy with a target price of 85p.
Stagecoach: RBC Capital Markets reiterates outperform with a target price of 160p.
TUI: Berenberg reiterates buy with a target price of 1,650p.
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 128.50p |
Change Today | 1.50p |
% Change | 1.18 % |
52 Week High | 128.50p |
52 Week Low | 81.00p |
Volume | 23,872 |
Shares Issued | 579.43m |
Market Cap | £744.56m |
RiskGrade | 195 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 3 |
Buy | 2 |
Neutral | 2 |
Sell | 0 |
Strong Sell | 0 |
Total | 7 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 25-Apr-24 | 14-Sep-23 |
Paid | 29-May-24 | 13-Oct-23 |
Amount | 4.37p | 2.91p |
Time | Volume / Share Price |
10:38 | 2,373 @ 126.94p |
10:38 | 386 @ 127.86p |
10:38 | 1,890 @ 127.86p |
10:31 | 1 @ 126.50p |
10:19 | 2 @ 127.86p |
CEO | Mike Edward |
CFO | Ben Waldron |
You are here: research